In this week’s top news pick from MedTech Strategist Market Pathways: China’s regulatory agency announced the formation of three expert advisory groups focused on artificial intelligence, additive manufacturing, and hearing devices.Subscribe now to read the full analysis
Welcome to MyStrategist, an online experience like no other in the medical device industry.
MedTech Strategist's complimentary Community Blog focuses on the people and the passion behind the global device space. Sign up for our e-Newsletter to receive new articles and video interviews directly to your inbox.e-Newsletter Browse
50 confirmed VCs & Investors attending Innovation Summit San Francisco, November 18-19th.Register Learn More Attendee List
'Meet the Innovators' Season 2, Episode 9: A video interview with William Altman, CEO, and Christina Bolch, PhD, Sr Biomedical Engineer, CorInnova. Houston-based start-up, CorInnova Inc., is developing a minimally invasive soft robotic cardiac device that they anticipate will shift the paradigm of existing heart failure (HF) treatments, and may reverse the progression of HF or even prevent its development in post-heart attack patients.Subscribe now to read the full analysis
Discover the opportunities and challenges that impact the global medtech regulatory and reimbursement community with MedTech Strategist Market Pathways.Subscribe Free Premier Issue Learn More
Clinical experience in lung and other cancers shows how precision medicine has implications for the medtech world, particularly in the area of tissue biopsies and interventional treatment procedures.Subscribe now to read the full analysis